Covered recipient · General Payments record
ERIK RICHARDSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$635.02
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $539.63 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $136.27 | 8 |
| ABBVIE INC. | $133.90 | 8 |
| Lilly USA, LLC | $76.06 | 4 |
| PFIZER INC. | $74.43 | 4 |
| Lundbeck LLC | $55.55 | 2 |
| Exact Sciences Corporation | $25.40 | 1 |
| Amgen Inc. | $19.50 | 1 |
| Nevro Corp. | $18.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.96 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945415 | CMS |
| ABBVIE INC. | $7.71 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945417 | CMS |
| ABBVIE INC. | $29.67 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945419 | CMS |
| ABBVIE INC. | $4.81 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945421 | CMS |
| ABBVIE INC. | $14.56 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945423 | CMS |
| ABBVIE INC. | $9.03 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945425 | CMS |
| ABBVIE INC. | $26.24 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945427 | CMS |
| ABBVIE INC. | $25.92 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105945429 | CMS |
| Amgen Inc. | $19.50 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117364349 | CMS |
| Exact Sciences Corporation | $25.40 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114854036 | CMS |
| Lilly USA, LLC | $17.05 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134968483 | CMS |
| Lilly USA, LLC | $22.51 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134973931 | CMS |
| Lilly USA, LLC | $15.18 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136170365 | CMS |
| Lilly USA, LLC | $21.32 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134968485 | CMS |
| Lundbeck LLC | $22.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145961208 | CMS |
| Lundbeck LLC | $32.85 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145961210 | CMS |
| Nevro Corp. | $18.52 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130782228 | CMS |
| Novo Nordisk Inc | $15.01 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096691863 | CMS |
| Novo Nordisk Inc | $23.13 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097045013 | CMS |
| Novo Nordisk Inc | $18.43 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097131263 | CMS |
| Novo Nordisk Inc | $13.48 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097760795 | CMS |
| Novo Nordisk Inc | $20.27 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097573323 | CMS |
| Novo Nordisk Inc | $12.24 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096921820 | CMS |
| Novo Nordisk Inc | $18.91 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097450313 | CMS |
| Novo Nordisk Inc | $14.80 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096618240 | CMS |
| PFIZER INC. | $20.02 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131153558 | CMS |
| PFIZER INC. | $21.96 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132019026 | CMS |
| PFIZER INC. | $15.41 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131679009 | CMS |
| PFIZER INC. | $17.04 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131233924 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.